大博医疗(002901.SZ)：2025年中报净利润为2.44亿元

Financial Performance - The company reported a total revenue of 1.21 billion yuan for the first half of 2025 [1] - The net profit attributable to shareholders was 244 million yuan [1] - The net cash inflow from operating activities was 263 million yuan [1] Key Financial Ratios - The latest debt-to-asset ratio stands at 25.91% [3] - The gross profit margin is reported at 71.01% [3] - The return on equity (ROE) is 7.77% [3] - The diluted earnings per share (EPS) is 0.60 yuan [3] - The total asset turnover ratio is 0.28 times [3] - The inventory turnover ratio is also 0.28 times [3] Shareholder Information - The number of shareholders is approximately 19,400 [3] - The top ten shareholders hold a total of 360 million shares, accounting for 86.93% of the total share capital [3] - The largest shareholder is Guangxi Dabo Business Communication Venture Investment Co., Ltd., holding 23.4% [3]